Tenet Healthcare is a Dallas-based healthcare services organization... Show more
As one of the largest investor-owned healthcare providers in the U.S., Tenet Healthcare operates acute care and specialty hospitals alongside a growing ambulatory care network focused on outpatient surgery centers. This Q1 2026 report is pivotal amid ongoing industry challenges like shifting payer mixes, labor costs, and reimbursement pressures. Investors closely watch volume trends, margin resilience, and cash generation, as Tenet has demonstrated consistent profitability growth over recent quarters. Strong ambulatory performance has offset hospital segment volatility, underscoring the company's strategic shift toward higher-margin outpatient services. These results provide insights into healthcare demand and operational efficiency in a post-pandemic environment.
Tenet Healthcare reported net operating revenues of $5.368 billion for the first quarter ended March 31, 2026, a 2.8% increase from $5.223 billion in Q1 2025. This topped company-provided prior-year figures but fell slightly short of Wall Street's $5.39 billion consensus.
Adjusted diluted earnings per share (EPS) soared to $4.82, up 10.6% YoY from $4.36 and well above the $4.21 estimate. GAAP diluted EPS reached $8.01, boosted by one-time items including $413 million from an early contract conclusion with CommonSpirit Health.
Consolidated adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) held at $1.162 billion (21.6% margin), flat YoY amid ambulatory gains offsetting hospital declines. The Ambulatory Care segment posted $484 million in adjusted EBITDA (36.7% margin), up 6.1%, with 5.3% same-facility system-wide revenue growth fueled by 5.6% higher revenue per case. Hospital Operations and Services saw $678 million adjusted EBITDA (16.7% margin), down YoY due to flat admissions (up 0.2%), softer outpatient volumes, and unfavorable payer mix; no prior-year Medicaid supplemental payments repeated.
Net cash provided by operating activities jumped to $1.641 billion, yielding $978 million in adjusted free cash flow.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your stock analysis workflow.
Despite the substantial EPS beat and record cash flow, Tenet Healthcare's shares declined in after-hours trading following the April 30 release, pressured by the revenue miss and weaker-than-expected hospital volumes. Investors appeared cautious on persistent challenges in the hospital segment, including declining outpatient and ER visits, amid unfavorable shifts toward lower-reimbursing exchange patients. Sentiment remains mixed, balancing ambulatory momentum against acute care headwinds, with focus shifting to guidance execution.
Tenet reaffirmed its full-year 2026 guidance, projecting net operating revenues of $21.5 billion to $22.3 billion and consolidated adjusted EBITDA of $4.485 billion to $4.785 billion (20.9% to 21.5% margin). Adjusted diluted EPS is expected at $16.38 to $18.68, with adjusted free cash flow of $2.5 billion to $2.8 billion supporting debt paydown and share repurchases.
In the Ambulatory Care segment, watch for 3.0% to 6.0% same-facility system-wide revenue growth and adjusted EBITDA of $2.13 billion to $2.23 billion, driven by acquisitions, service mix improvements, and volume recovery. Hospital Operations guidance calls for 1.0% to 2.0% growth in inpatient and adjusted admissions, with revenues of $16.0 billion to $16.6 billion and EBITDA of $2.355 billion to $2.555 billion.
Key monitors include payer mix stabilization, expense discipline amid labor and supply costs, and ambulatory expansion via M&A (mergers and acquisitions). Non-recurring items like the CommonSpirit settlement won't repeat, so underlying trends in acuity, surgical volumes, and reimbursement rates will be critical. Broader healthcare dynamics, such as Medicaid redeterminations and elective procedure demand, could influence trajectory.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of health care services
Industry HospitalNursingManagement